MIF-1 attenuates spiroperidol alteration of striatal dopamine D2 receptor ontogeny
- 1 January 1989
- Vol. 10 (1) , 35-39
- https://doi.org/10.1016/0196-9781(89)90072-7
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Mesolimbic and striatal dopamine receptor supersensitivity: Prophylactic and reversal effects of L-prolyl-L-leucyl-glycinamide (PLG)Peptides, 1985
- Dose-dependent effects of prolyl-leucyl-glycinamide on morphine-induced analgesia, tolerance and dependenceEuropean Journal of Pharmacology, 1984
- Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on the supersensitivity of dopamine receptors in brain induced by chronic administration of haloperidol to ratsNeuropharmacology, 1984
- Enhanced striatal 3H-spiroperidol binding induced by chronic haloperidol treatment inhibited by peptides administered during the withdrawal phaseLife Sciences, 1984
- Binding of 63H9spiroperidol to striatal membranes of rats treated chronically with morphine Influence of pro-Leu-Gly-NH2 and cyclo(Leu-Gly)Neuropharmacology, 1983
- Effect of peptides on the development of tolerance to buprenorphine, a mixed opiate agonist-antagonist analgesicEuropean Journal of Pharmacology, 1982
- Neuroleptic Drug-Induced Dopamine Receptor Supersensitivity: Antagonism by L-Prolyl-L-Leucyl-GlycinamideScience, 1981
- THE EFFECT OF MELANOTROPHIN RELEASE INHIBITING FACTOR (MIF) AND CYCLO (LEU‐GLY) ON THE TOLERANCE TO MORPHINE‐INDUCED ANTINOCICEPTION IN THE RAT: A DOSE‐RESPONSE STUDYBritish Journal of Pharmacology, 1981
- Effect of L-prolyl-L-leucyl-glycinamide (PLG) on neuroleptic-induced catalepsy and dopamine/neuroleptic receptor bindingsPeptides, 1981
- Antischizophrenic Drugs: Chronic Treatment Elevates Dopamine Receptor Binding in BrainScience, 1977